The head of Europe's drugs regulator is braced for
disruption following Britain's vote to leave the European Union
(EU) and said he feared losing expert staff if, as widely expected,
the regulator is forced to decamp from London.
The European Medicines Agency (EMA) approves treatments for all
EU countries from its headquarters among global banks in London's
Canary Wharf. It is the largest EU body in Britain.
"My concern is to lose experts, to lose staff," Executive
Director Guido Rasi told an industry conference on Tuesday.
Most industry watchers believe Britain's decision to leave the
EU will mean Europe's equivalent of the U.S. Food and Drug
Administration is forced to move to a city within the EU, although
there has been no official announcement on this.
EU countries including Spain, France, Poland, Italy, Sweden,
Denmark and Ireland have already offered to host the EMA instead of
Britain and the tussle over its future location is expected to form
part of complex political horse-trading.
The European Banking Authority is also based in London.
"I'm flattered that so many different nations want us but my
concern is workability," Rasi told the Pharma Integrates
conference.
The EMA employs nearly 900 people, many of whom have made a
long-term home in London, since the agency has been based here for
the past two decades, he said.
Losing Britain could also leave a big hole in the EMA's
scientific capability, since British experts are among the biggest
contributors to its drug assessment system.
Rasi said the EMA had set up a task force to address the
challenges arising following the Brexit vote but noted that the
decision on if and when the agency would move was up to European
politicians.
Irish Health Minister Simon Harris, announcing Dublin as a
candidate to house the EMA last month, said it appeared inevitable
that the EMA would have to relocate from London to another EU
member state.
Housing the industry regulator is viewed as a valuable prize for
European cities, since it will lead to an injection of a skilled
workforce and potentially attract companies.